Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 9/2019

Open Access 01-09-2019 | Magnetic Resonance Imaging | Neuroimaging (N. Pavese, Section Editor)

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease

Authors: Andreas–Antonios Roussakis, Nicholas P. Lao–Kaim, Paola Piccini

Published in: Current Neurology and Neuroscience Reports | Issue 9/2019

Login to get access

Abstract

Purpose of Review

Parkinson’s disease (PD) has a wide spectrum of symptoms including the presence of psychiatric disease. At present, most treatment plans, comprised of dopaminergic drugs, are chronic and complex. Though dopaminergic agents are quite efficient in managing the motor aspects of the disease, chronic pharmacotherapy specifically with dopamine receptor agonists has been highly linked to the occurrence of Impulse Compulsive disorder (ICD), which can be problematic for individual patients.

Recent Findings

Much of what is known today about PD-related ICD stems from brain imaging studies, however, evidence is not quite conclusive. Research in the field has been focused on identifying the underlying mechanisms of PD-related ICD and understanding the functions of the structures involved in the reward network.

Summary

This article presents an update of recent findings from key neuroimaging studies in PD-related ICD, discusses results from controversial studies, and identifies areas for future research in the field.
Literature
1.
go back to reference Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord. 2012;18:155–60.CrossRef Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord. 2012;18:155–60.CrossRef
2.
go back to reference Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis. 2013;11:63–71.CrossRef Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis. 2013;11:63–71.CrossRef
3.
go back to reference Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, et al. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update. Lancet Neurol. 2017;16:238–50.CrossRef Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, et al. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update. Lancet Neurol. 2017;16:238–50.CrossRef
4.
go back to reference Ramirez-Zamora A, Gee L, Boyd J, Biller J. Treatment of impulse control disorders in Parkinson's disease: practical considerations and future directions. Expert Rev Neurother. 2016;16:389–99.CrossRef Ramirez-Zamora A, Gee L, Boyd J, Biller J. Treatment of impulse control disorders in Parkinson's disease: practical considerations and future directions. Expert Rev Neurother. 2016;16:389–99.CrossRef
6.
go back to reference Sturm V, Lenartz D, Koulousakis A, Treuer H, Herholz K, Klein JC, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26:293–9.CrossRef Sturm V, Lenartz D, Koulousakis A, Treuer H, Herholz K, Klein JC, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26:293–9.CrossRef
7.
go back to reference Franzini A, Messina G, Gambini O, Muffatti R, Scarone S, Cordella R, et al. Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci. 2010;31:353–9.CrossRef Franzini A, Messina G, Gambini O, Muffatti R, Scarone S, Cordella R, et al. Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci. 2010;31:353–9.CrossRef
8.
go back to reference Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF. Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest study. J Park Dis. 2017;7:183–91. Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF. Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest study. J Park Dis. 2017;7:183–91.
9.
go back to reference Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson's disease patients. Parkinsonism Relat Disord. 2014;20:907–10.CrossRef Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson's disease patients. Parkinsonism Relat Disord. 2014;20:907–10.CrossRef
10.
go back to reference Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017;88:317–24.CrossRef Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017;88:317–24.CrossRef
11.
go back to reference Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: assessment using “questionnaire for impulsive-compulsive disorders in Parkinson's disease” (QUIP). Ann Indian Acad Neurol. 2015;18:49–59.CrossRef Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: assessment using “questionnaire for impulsive-compulsive disorders in Parkinson's disease” (QUIP). Ann Indian Acad Neurol. 2015;18:49–59.CrossRef
12.
go back to reference Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, et al. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease. Mov Disord. 2015;30:141–9.CrossRef Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, et al. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease. Mov Disord. 2015;30:141–9.CrossRef
13.
go back to reference Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68:301–3.CrossRef Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68:301–3.CrossRef
14.
go back to reference Evans AH, Stegeman JR. Punding in patients on dopamine agonists for restless leg syndrome. Mov Disord. 2009;24:140–1.CrossRef Evans AH, Stegeman JR. Punding in patients on dopamine agonists for restless leg syndrome. Mov Disord. 2009;24:140–1.CrossRef
15.
go back to reference Fan W, Ding H, Ma J, Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett. 2009;465:6–9.CrossRef Fan W, Ding H, Ma J, Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett. 2009;465:6–9.CrossRef
16.
go back to reference Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589–95.CrossRef Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589–95.CrossRef
17.
go back to reference Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C, et al. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clin Neuropharmacol. 2012;35:261–5.CrossRef Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C, et al. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clin Neuropharmacol. 2012;35:261–5.CrossRef
18.
go back to reference Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction. 2011;106:283–93.CrossRef Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction. 2011;106:283–93.CrossRef
19.
go back to reference Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol. 2011;24:324–30.CrossRef Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol. 2011;24:324–30.CrossRef
20.
go back to reference Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction. 2011;106:490–8.CrossRef Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction. 2011;106:490–8.CrossRef
21.
go back to reference Coleman E, Raymond N, McBean A. Assessment and treatment of compulsive sexual behavior. Minn Med. 2003;86:42–7.PubMed Coleman E, Raymond N, McBean A. Assessment and treatment of compulsive sexual behavior. Minn Med. 2003;86:42–7.PubMed
22.
go back to reference Lejoyeux M, Weinstein A. Compulsive buying. Am J Drug Alcohol Abuse. 2010;36:248–53.CrossRef Lejoyeux M, Weinstein A. Compulsive buying. Am J Drug Alcohol Abuse. 2010;36:248–53.CrossRef
23.
go back to reference Lejoyeux M, Lehert P. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies. Alcohol Alcohol. 2011;46:61–7.CrossRef Lejoyeux M, Lehert P. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies. Alcohol Alcohol. 2011;46:61–7.CrossRef
24.
go back to reference Strafella AP. Mesolimbic dopamine and anterior cingulate cortex connectivity changes lead to impulsive behaviour in Parkinson's disease. Brain. 2019;142:496–8.CrossRef Strafella AP. Mesolimbic dopamine and anterior cingulate cortex connectivity changes lead to impulsive behaviour in Parkinson's disease. Brain. 2019;142:496–8.CrossRef
25.
go back to reference Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 1996;6:228–36.CrossRef Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 1996;6:228–36.CrossRef
26.
go back to reference Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275:1593–9.CrossRef Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275:1593–9.CrossRef
28.
go back to reference Fudge JL, Haber SN. Defining the caudal ventral striatum in primates: cellular and histochemical features. J Neurosci. 2002;22:10078–82.CrossRef Fudge JL, Haber SN. Defining the caudal ventral striatum in primates: cellular and histochemical features. J Neurosci. 2002;22:10078–82.CrossRef
29.
go back to reference Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry. 2003;160:1726–39.CrossRef Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry. 2003;160:1726–39.CrossRef
30.
go back to reference Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord. 2010;25:1660–9.CrossRef Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord. 2010;25:1660–9.CrossRef
31.
go back to reference Petersen K, Van Wouwe N, Stark A, Lin YC, Kang H, Trujillo-Diaz P, et al. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson’s disease. Hum Brain Mapp. 2018;39:509–21.CrossRef Petersen K, Van Wouwe N, Stark A, Lin YC, Kang H, Trujillo-Diaz P, et al. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson’s disease. Hum Brain Mapp. 2018;39:509–21.CrossRef
32.
go back to reference Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology. 2015;84:2116–23.CrossRef Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology. 2015;84:2116–23.CrossRef
33.
go back to reference Tessitore A, Santangelo G, De Micco R, Giordano A, Raimo S, Amboni M, et al. Resting-state brain networks in patients with Parkinson's disease and impulse control disorders. Cortex. 2017;94:63–72.CrossRef Tessitore A, Santangelo G, De Micco R, Giordano A, Raimo S, Amboni M, et al. Resting-state brain networks in patients with Parkinson's disease and impulse control disorders. Cortex. 2017;94:63–72.CrossRef
34.
go back to reference Markovic V, Agosta F, Canu E, Inuggi A, Petrovic I, Stankovic I, et al. Role of habenula and amygdala dysfunction in Parkinson disease patients with punding. Neurology. 2017;88:2207–15.CrossRef Markovic V, Agosta F, Canu E, Inuggi A, Petrovic I, Stankovic I, et al. Role of habenula and amygdala dysfunction in Parkinson disease patients with punding. Neurology. 2017;88:2207–15.CrossRef
35.
go back to reference Filip P, Linhartová P, Hlavatá P, Šumec R, Baláž M, Bareš M, et al. Disruption of multiple distinctive neural networks associated with impulse control disorder in Parkinson's disease. Front Hum Neurosci. 2018;12:462.CrossRef Filip P, Linhartová P, Hlavatá P, Šumec R, Baláž M, Bareš M, et al. Disruption of multiple distinctive neural networks associated with impulse control disorder in Parkinson's disease. Front Hum Neurosci. 2018;12:462.CrossRef
36.
go back to reference Pellicano C, Niccolini F, Wu K, O'Sullivan SS, Lawrence AD, Lees AJ, et al. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders. J Neurol. 2015;262:2653–61.CrossRef Pellicano C, Niccolini F, Wu K, O'Sullivan SS, Lawrence AD, Lees AJ, et al. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders. J Neurol. 2015;262:2653–61.CrossRef
37.
go back to reference Tessitore A, Santangelo G, De Micco R, Vitale C, Giordano A, Raimo S, et al. Cortical thickness changes in patients with Parkinson’s disease and impulse control disorders. Parkinsonism Relat Disord. 2016;24:119–25.CrossRef Tessitore A, Santangelo G, De Micco R, Vitale C, Giordano A, Raimo S, et al. Cortical thickness changes in patients with Parkinson’s disease and impulse control disorders. Parkinsonism Relat Disord. 2016;24:119–25.CrossRef
38.
go back to reference Ricciardi L, Lambert C, De Micco R, Morgante F, Edwards M. Can we predict development of impulsive-compulsive behaviours in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2018;89:476–81.CrossRef Ricciardi L, Lambert C, De Micco R, Morgante F, Edwards M. Can we predict development of impulsive-compulsive behaviours in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2018;89:476–81.CrossRef
39.
go back to reference Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, et al. Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease. Mol Psychiatry. 2018;23:459–66.CrossRef Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, et al. Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease. Mol Psychiatry. 2018;23:459–66.CrossRef
40.
go back to reference Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, et al. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov Disord. 2015;30:688–95.CrossRef Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, et al. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov Disord. 2015;30:688–95.CrossRef
41.
go back to reference Canu E, Agosta F, Markovic V, Petrovic I, Stankovic I, Imperiale F, et al. White matter tract alterations in Parkinson's disease patients with punding. Parkinsonism Relat Disord. 2017;43:85–91.CrossRef Canu E, Agosta F, Markovic V, Petrovic I, Stankovic I, Imperiale F, et al. White matter tract alterations in Parkinson's disease patients with punding. Parkinsonism Relat Disord. 2017;43:85–91.CrossRef
42.
go back to reference Mojtahed Zadeh M, Ashraf-Ganjouei A, Ghazi Sherbaf F, Haghshomar M, Aarabi MH. White matter tract alterations in drug-Naïve Parkinson's disease patients with impulse control disorders. Front Neurol. 2018;9:163.CrossRef Mojtahed Zadeh M, Ashraf-Ganjouei A, Ghazi Sherbaf F, Haghshomar M, Aarabi MH. White matter tract alterations in drug-Naïve Parkinson's disease patients with impulse control disorders. Front Neurol. 2018;9:163.CrossRef
43.
go back to reference Yoo HB, Lee JY, Lee JS, Kang H, Kim YK, Song IC, et al. Whole-brain diffusion-tensor changes in parkinsonian patients with impulse control disorders. J Clin Neurol. 2015;11:42–7.CrossRef Yoo HB, Lee JY, Lee JS, Kang H, Kim YK, Song IC, et al. Whole-brain diffusion-tensor changes in parkinsonian patients with impulse control disorders. J Clin Neurol. 2015;11:42–7.CrossRef
44.
go back to reference Thiel A, Hilker R, Kessler J, Habedank B, Herholz K, Heiss WD. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm (Vienna). 2003;110:1289–301.CrossRef Thiel A, Hilker R, Kessler J, Habedank B, Herholz K, Heiss WD. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm (Vienna). 2003;110:1289–301.CrossRef
45.
go back to reference van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75:1711–6.CrossRef van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75:1711–6.CrossRef
46.
go back to reference Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F, et al. Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions. Hum Brain Mapp. 2014;35:2499–506.CrossRef Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F, et al. Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions. Hum Brain Mapp. 2014;35:2499–506.CrossRef
47.
go back to reference Tahmasian M, Rochhausen L, Maier F, Williamson KL, Drzezga A, Timmermann L, et al. Impulsivity is associated with increased metabolism in the Fronto-insular network in Parkinson's disease. Front Behav Neurosci. 2015;9:317.CrossRef Tahmasian M, Rochhausen L, Maier F, Williamson KL, Drzezga A, Timmermann L, et al. Impulsivity is associated with increased metabolism in the Fronto-insular network in Parkinson's disease. Front Behav Neurosci. 2015;9:317.CrossRef
48.
go back to reference • Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson's disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39:3178–86 Using a non-conventional approach to metabolic connectivity involving 18 F-FDG PET, this study shows that network dysfunction in Parkinson’s-related impulse control disorder extends beyond the mesocorticolimbic system. CrossRef • Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson's disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39:3178–86 Using a non-conventional approach to metabolic connectivity involving 18 F-FDG PET, this study shows that network dysfunction in Parkinson’s-related impulse control disorder extends beyond the mesocorticolimbic system. CrossRef
49.
go back to reference Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132:1376–85.CrossRef Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132:1376–85.CrossRef
50.
go back to reference Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48:519–25.CrossRef Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48:519–25.CrossRef
51.
go back to reference O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain. 2011;134:969–78.CrossRef O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain. 2011;134:969–78.CrossRef
52.
go back to reference Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Bose S, et al. Single versus multiple impulse control disorders in Parkinson's disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol. 2015;262:1504–14.CrossRef Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Bose S, et al. Single versus multiple impulse control disorders in Parkinson's disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol. 2015;262:1504–14.CrossRef
53.
go back to reference Joutsa J, Voon V, Johansson J, Niemelä S, Bergman J, Kaasinen V. Dopaminergic function and intertemporal choice. Transl Psychiatry. 2015;5:e491.CrossRef Joutsa J, Voon V, Johansson J, Niemelä S, Bergman J, Kaasinen V. Dopaminergic function and intertemporal choice. Transl Psychiatry. 2015;5:e491.CrossRef
54.
go back to reference Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, et al. [11C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Mov Disord. 2015;30:160–6.CrossRef Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, et al. [11C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Mov Disord. 2015;30:160–6.CrossRef
55.
go back to reference •• Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, et al. Nigrostriatal and mesolimbic D2/3 receptor expression in Parkinson's disease patients with compulsive reward-driven behaviors. J Neurosci. 2018;38:3230–9 This is the first study to show that in Parkinson’s disease, impulse control disorder relates to widespread post-synaptic dopaminergic alterations in both striatal and extrastriatal regions. CrossRef •• Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, et al. Nigrostriatal and mesolimbic D2/3 receptor expression in Parkinson's disease patients with compulsive reward-driven behaviors. J Neurosci. 2018;38:3230–9 This is the first study to show that in Parkinson’s disease, impulse control disorder relates to widespread post-synaptic dopaminergic alterations in both striatal and extrastriatal regions. CrossRef
56.
go back to reference Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, Song IC, et al. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry. 2014;85:23–30.CrossRef Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, Song IC, et al. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry. 2014;85:23–30.CrossRef
57.
go back to reference Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85:148–52.CrossRef Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85:148–52.CrossRef
58.
go back to reference Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. Mov Disord. 2014;29:904–11.CrossRef Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. Mov Disord. 2014;29:904–11.CrossRef
59.
go back to reference Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87:864–70.CrossRef Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87:864–70.CrossRef
60.
go back to reference Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale. Mov Disord. 2012;27:242–7.CrossRef Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale. Mov Disord. 2012;27:242–7.CrossRef
61.
go back to reference • Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, et al. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain. 2019;142:733–43 This multi-modal imaging study provides significant evidence for the role of the nucleus accumbens (low dopamine synthesis and reduced functional connectivity with the rostral anterior cingulate cortex) in the development of impulse control disorder. CrossRef • Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, et al. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain. 2019;142:733–43 This multi-modal imaging study provides significant evidence for the role of the nucleus accumbens (low dopamine synthesis and reduced functional connectivity with the rostral anterior cingulate cortex) in the development of impulse control disorder. CrossRef
Metadata
Title
Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
Authors
Andreas–Antonios Roussakis
Nicholas P. Lao–Kaim
Paola Piccini
Publication date
01-09-2019
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 9/2019
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-019-0980-5

Other articles of this Issue 9/2019

Current Neurology and Neuroscience Reports 9/2019 Go to the issue

Headache (R.B. Halker Singh, Section Editor)

Updates in the Diagnosis and Management of Giant Cell Arteritis

Neurotrauma (D. Sandsmark, Section Editor)

Semiology and Mechanisms of Near-Death Experiences

Stroke (H.C. Diener, Section Editor)

Multimodal CT in Acute Stroke

Neurotrauma (D. Sandsmark, Section Editor)

Modern Medical Management of Spinal Cord Injury

Sleep (M. Thorpy and M. Billiard, Section Editors)

The Comorbidity of Migraine and Restless Legs Syndrome